Description

Eicosanoid and docosanoid metabolite pathways derived from EPA and DHA respectively are depicted, showing how each produces distinct families of specialized pro-resolving mediators.

Figure 4

Diagram

Source Paper

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?

Nutrients (2020)

PMID: 33276463

DOI: 10.3390/nu12123718

Cite This Figure

![Figure 4: Eicosanoid and docosanoid metabolite pathways derived from EPA and DHA respectively are depicted, showing how each produces distinct families of specialized pro-resolving mediators.]()

> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)

<figure>
  <img src="" alt="Eicosanoid and docosanoid metabolite pathways derived from EPA and DHA respectively are depicted, showing how each produces distinct families of specialized pro-resolving mediators." />
  <figcaption>Figure 4. Eicosanoid and docosanoid metabolite pathways derived from EPA and DHA respectively are depicted, showing how each produces distinct families of specialized pro-resolving mediators.<br>  Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption>
</figure>

Preuves associées

Omega-3 Fatty Acids (EPA/DHA) pour Chronic Inflammation

Note A · 30 études